Hepatitis C (HCV) infects an estimated 150 million people worldwide. It has proven to be a major cause of concern for medical professionals since it can also lead…
Hepatitis C is an RNA flavivirus that infects 4 million people in the United States, making it the leading indicator for liver transplant in the US. It has…
NEW YORK (Reuters Health) – In HIV-infected patients, risk factors for thrombocytopenia include interruptions in antiretroviral therapy, high HIV RNA levels, hepatitis C virus (HCV) infection, and cirrhosis,…
NEW YORK (Reuters Health) – A low platelet count in the presence of hepatitis C viremia indicates the need to begin interferon-based treatment, regardless of the degree of…
NEW YORK (Reuters Health) – Liver transplant recipients whose indication for transplant was hepatitis C virus (HCV) cirrhosis have markedly poorer survival compared to patients transplanted for alcoholic…
NEW YORK (Reuters Health) – Depression related to peginterferon therapy for chronic hepatitis C increases with duration of use, but reverses following treatment cessation, according to data from…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology from Northwestern University provides an overview of the treatment of hepatitis C. References and Resources Seef, LB, Hoofnagle, JH. National…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology from Northwestern University provides an overview of the epidemiology and diagnosis of hepatitis C. References and Resources Armstrong GL. The…
